Antagonism of epidermal growth factor receptor signaling favors hepatitis E virus life cycle
Journal of Virology · 2024
DOI: 10.1128/jvi.00580-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Kathrin Woytinek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Virology, Paul Ehrlich Institute, Langen, Germany. Hauptthemen laut MEDLINE: Hepatitis E virus, ErbB Receptors, Virus Replication, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LOEWE DRUID.
Abstract (Originalsprache)
Hepatitis E virus (HEV) poses a global threat, which currently remains understudied in terms of host interactions. Epidermal growth factor receptor (EGFR) plays multifaceted roles in viral pathogenesis, impacting host-cell entry, viral replication, and host-defense modulation. On the one hand, EGFR signaling emerged as a major driver in innate immunity; on the other hand, a crosstalk between HEV and EGFR requires deeper analysis. We therefore aimed to dissect the receptor’s involvement in the HEV life cycle. In persistently HEV-infected cells, the EGFR amount is decreased alongside with enhanced receptor internalization. As compared with the control ligand-induced EGFR, activation revealed an early receptor internalization and degradation in HEV-replicating cells, resulting in a notable EGFR signaling delay. Interestingly, inhibition or silencing of EGFR increased viral replication, extracellular and intracellular viral transcripts, and released infectious particles. The pro-viral impact of EGFR inhibition was attributed to (i) impaired expression of interferon-stimulated genes, (ii) activation of the autophagosomal system, (iii) virus-induced inhibition of lysosomal acidification, and (iv) a decrease of the cellular cholesterol level. IMPORTANCE This study identifies epidermal growth factor receptor (EGFR) as a novel host factor affecting hepatitis E virus (HEV): EGFR downregulation promotes viral replication, release, and evasion from the innate immune response. The discovery that EGFR inhibition favors viral spread is particularly concerning for HEV patients undergoing EGFR inhibitor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Virology, Paul Ehrlich Institute, Langen, Germany.
ORCID-Profile: Kathrin Woytinek, Eberhard Hildt
Förderung
- LOEWE DRUID
Zitieren
APA
Woytinek, K., Glitscher, M., & Hildt, E. (2024). Antagonism of epidermal growth factor receptor signaling favors hepatitis E virus life cycle. Journal of Virology. https://doi.org/10.1128/jvi.00580-24
Vancouver
Woytinek K, Glitscher M, Hildt E. Antagonism of epidermal growth factor receptor signaling favors hepatitis E virus life cycle. Journal of Virology. 2024. doi:10.1128/jvi.00580-24
BibTeX
@article{Woytinek2024,
author = {Woytinek, Kathrin and Glitscher, Mirco and Hildt, Eberhard},
title = {Antagonism of epidermal growth factor receptor signaling favors hepatitis E virus life cycle},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.00580-24}
}
EUVIMED